Log In
Print
BCIQ
Print
Print this Print this
 

OSE 2101 (formerly EP-2101, EP2101, IDM-2101)

  Manage Alerts
Collapse Summary General Information
Company EU Synergy Epitopes S.A.
DescriptionVaccine containing 9 modified epitopes plus the PADRE universal helper T lymphocyte epitope targeting 5 tumor-associated antigens (TAA)
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today